Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mahamaya LifesciencesBOM:544611 16 PB Ratio is 3.20 as of Aug. 02, 2026, which is 42% below its 10-year median of 5.50. GuruFocus rates BOM:544611 with a GF Score™ of 16/100. The stock has 4 warning signs investors should review. Among 248 Agriculture companies, Mahamaya Lifesciences ranks worse than 82.26% on this metric.
Mahamaya Lifesciences Ltd stock PB Ratio (=3.19) is close to 1-year low of 3.04.
The historical rank and industry rank for Mahamaya Lifesciences's PB Ratio or its related term are showing as below:
BOM:544611'
s PB Ratio Range Over the Past 10 Years
Min: 3.04 Med: 5.5 Max: 9.33
Current: 3.23
During the past 5 years, Mahamaya Lifesciences's highest PB Ratio was 9.33. The lowest was 3.04. And the median was 5.50.
BOM:544611's PB Ratio is ranked worse than 82.26% of 248
companies
in the Agriculture industry
Industry Median: 1.525
vs BOM:544611: 3.23
During the past 12 months, Mahamaya Lifesciences's average Book Value Per Share Growth Rate was 146.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 84.40% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Mahamaya Lifesciences was 84.40% per year. The lowest was 46.50% per year. And the median was 65.45% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Agricultural Inputs subindustry, Mahamaya Lifesciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mahamaya Lifesciences PB Ratio vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Mahamaya Lifesciences's PB Ratio distribution charts can be found below:
* The bar in red indicates where Mahamaya Lifesciences's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Mahamaya Lifesciences (BOM:544611) has a PB Ratio of 3.20 as of Aug. 02, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Mahamaya Lifesciences and its competitors. This is 42% below median its historical median of 5.50. Over the past decade, Mahamaya Lifesciences' PB Ratio has ranged from 3.04 to 9.33. According to the industry distribution chart, Mahamaya Lifesciences ranks #204 out of 248 companies in the Agriculture industry, placing it in the top 82.3%.
Is Mahamaya Lifesciences' PB Ratio too high?
Mahamaya Lifesciences' current PB Ratio of 3.20 is 42% below median its 10-year median of 5.50. Over the past 10 years, this metric has ranged from a low of 3.04 to a high of 9.33. The Agriculture industry median PB Ratio is 1.53. Mahamaya Lifesciences' value of 3.20 is 109.8% above this industry median. Based on the distribution chart, Mahamaya Lifesciences ranks #204 out of 248 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, Mahamaya Lifesciences has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Mahamaya Lifesciences' PB Ratio compare to CTVA and CF?
According to the Agriculture industry distribution chart, Mahamaya Lifesciences ranks #204 out of 248 companies for PB Ratio. This places Mahamaya Lifesciences in the lower half of its industry. The industry median PB Ratio is 1.53. Mahamaya Lifesciences' value of 3.20 is 109.8% above this benchmark. Historically, Mahamaya Lifesciences' own PB Ratio has ranged from 3.04 to 9.33 over the past decade. While the company's 10-year median is 5.50 vs. the industry median of 1.53, Mahamaya Lifesciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for an Agriculture company?
The median PB Ratio among Agriculture companies is 1.53, based on 248 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mahamaya Lifesciences's current PB Ratio of 3.20 is 109.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Mahamaya Lifesciences and its competitors. For the Agriculture industry, the median PB Ratio is 1.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mahamaya Lifesciences's current PB Ratio is 3.20, which is 42% below median its own 10-year median of 5.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mahamaya Lifesciences stock overvalued right now?
Mahamaya Lifesciences (BOM:544611) has a current PB Ratio of 3.20. The current PB Ratio is 3.20, which is 42% below median its 10-year median of 5.50 and 109.8% above the Agriculture industry median of 1.53. Mahamaya Lifesciences' overall GF Score™ is 16/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Mahamaya Lifesciences (BOM:544611), the current PB Ratio is 3.20 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Mahamaya Lifesciences Ltd specializes in the manufacturing of pesticide formulations and supplies bulk formulations catering to both Indian agrochemical companies as well as multinational corporations (MNCs). The company's offerings include Insecticides, Herbicides, and Fungicides. Geographically, it serves multiple Indian states including Punjab, Haryana, Rajasthan, and Uttar Pradesh, and internationally serves countries like the Dominican Republic, Turkey, Egypt, and the UAE. The company generates revenue from the sale of its pesticide formulations.
16GF Score
Get the complete analysis for BOM:544611
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544611 has been successfully added to your 
